See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/342666052
Association between stress/anxiety, depression, pain and quality of life in people with chronic kidney disease
Article in Revista Portuguesa de Enfermagem de Saúde Mental · July 2020 DOI: 10.19131/rpesm.0272 CITATIONS 0 READS 19 6 authors, including:
Some of the authors of this publication are also working on these related projects: Comfort: Needs, Interventions and outcomesView project
SimulationView project Luís Manuel Mota Sousa
Universidade de Évora 200PUBLICATIONS 493CITATIONS
SEE PROFILE
Olga Sousa Valentim
Atlântica
72PUBLICATIONS 39CITATIONS
SEE PROFILE
Cristina Marques-Vieira
Universidade Católica Portuguesa 98PUBLICATIONS 346CITATIONS
SEE PROFILE
Vanessa Antunes
Cooperativa de Ensino Superior Egas Moniz 41PUBLICATIONS 122CITATIONS
SEE PROFILE
7
ASSOCIATION BETWEEN STRESS/ANXIETY, DEPRESSION, PAIN AND
QUALITY OF LIFE IN PEOPLE WITH CHRONIC KIDNEY DISEASE
ABSTRACT
BACKGROUND: Chronic kidney disease patients undergoing hemodialysis have a high symptom burden that contributes to increased suf-fering and diminishes their quality of life. Cardiovascular, musculoskeletal and psychosocial disorders affect their physical and functional capacity anxiety, stress and depression.
AIM: To determine the prevalence of stress/anxiety and depression in people with chronic kidney disease and to verify the association be-tween stress/anxiety and depression with pain and quality of life.
METHODS: A cross-sectional, descriptive and correlational study; A random sample of 183 patients who underwent hemodialysis; appli-cation of the depression and stress anxiety scale (DASS-21), brief pain inventory (BPI), and Medical Outcomes Study Short-Form 12-Item Health Survey (SF-12).
RESULTS: The sample consisted mostly of men (59.6%), married (53.8%), Portuguese nationality (78.7%), mean age 59.17 years (SD ± 14.64), hemodialysis treatment 70.9 months (SD ± 54.2). 76% were retired and 24% had a regular job. The prevalence of stress and anxiety was 24% and depression was 37.2%.
CONCLUSIONS: Stress / anxiety and depression are prevalent in people with chronic kidney disease. Stress / anxiety and depression are as-sociated with high levels of pain, which impacts on activities of daily living, presenting low levels of quality of life in the physical and mental components.
KEYWORDS: Quality of life; Depression; Anxiety; Chronic renal insufficiency
Citação: Sousa, L., Valentim, O., Marques-Vieira, C., Antunes, A. V., Severino, S., & José, H. (2020). Association between stress/anxiety, depression, pain and quality of life in
people with chronic kidney disease. Revista Portuguesa de Enfermagem de Saúde Mental (23), 47-53.
| Luís Sousa1; Olga Valentim2; Cristina Marques-Vieira3; Ana Vanessa Antunes4; Sandy Severino5; Helena José6 |
1 Doutor em Enfermagem; Investigador Integrado no Comprehensive Health Research Centre; Professor Adjunto na Universidade de Évora, Portugal, luismmsousa@gmail.com 2 Doutora em Enfermagem; Investigadora Integrada no CINTESIS – Centro de Investigação em Tecnologias e Serviços de Saúde, grupo de investigação “NursID: Inovação e Desenvolvimento em Enfermagem”; Professora Adjunta na Escola Superior de Saúde do Instituto Politécnico de Leiria, Portugal, ommvalentim3@gmail.com
3 Doutora em Enfermagem; Investigadora Integrada no Centro de Investigação Interdisciplinar em Saúde; Professora Auxiliar na Universidade Católica Portuguesa, Instituto de Ciências de Saúde, Escola de Enfermagem, Lisboa, Portugal, cristina_marques@ics.lisboa.ucp.pt
4 Doutora em Saúde Pública; Membro Integrado do Centro de Investigação Interdisciplinar Egas Moniz, Professora Auxiliar na Escola Superior de Saúde Egas Moniz, Monte de Caparica, Almada, Portugal, vanessa2em@gmail.com
5 Mestre em Gestão da Saúde; Enfermeira Especialista na ARS de Lisboa e Vale do Tejo, ACES Loures-Odivelas, Sacavém, Portugal, sandyseverino@gmail.com
6 Doutora em Enfermagem; Investigadora na Health Sciences Research Unit: Nursing; Professora Adjunta na Universidade do Algarve, Faro, Portugal, helenamgjose@gmail.com RESUMO
“Associação entre stress/ansiedade, depressão, dor e qualidade de vida em pessoas com doença renal crónica”
CONTEXTO: As pessoas com doença renal crónica, em programa de
he-modiálise, apresentam sintomas que contribuem para aumentar o sofri-mento e diminuir a sua qualidade de vida. Apresentam vários problemas cardiovasculares, músculo-esqueléticos e psicossociais que afetam a sua capacidade física e funcional, podendo aumentar a ansiedade, stresse e de-pressão.
OBJETIVO(S): Determinar a prevalência de stresse / ansiedade e depressão
em pessoas com doença renal crónica e verificar a associação entre o stresse / ansiedade e depressão com a dor e a qualidade de vida.
MÉTODOS: Estudo transversal, descritivo e correlacional, Amostra
ale-atória composta por 183 utentes em programa de hemodiálise; aplicação da escala de ansiedade, depressão e stresse (DASS-21), inventário breve de dor e Medical Outcomes Study Short-Form 12-Item Health Survey (SF-12).
RESULTADOS: A amostra foi maioritariamente constituída por homens
(59,6%), casados (53,8%), de nacionalidade portuguesa (78,7%), com mé-dia de idade de 59,17 anos (DP ±14,64), sob tratamento hemomé-dialítico há 70,9 meses (DP ±54,2). 76% estavam reformados e 24% tinham um emprego regular. A prevalência do stresse e ansiedade foi de 24% e da depressão foi de 37,2%.
CONCLUSÕES: O stresse/ansiedade e depressão são prevalentes em
pes-soas com doença renal crónica. O stresse/ansiedade e depressão estão as-sociados a altos níveis de dor, com impacto nas atividades da vida diária, e a baixos níveis de qualidade de vida nos componentes físico e mental.
PALAVRAS-CHAVE: Qualidade de vida; Depressão; Ansie-dade; Insuficiência renal crónica
RESUMEN
“Asociación entre estrés / ansiedad, depresión, dolor y calidad de vida en personas con enfermedad renal crónica”
CONTEXTO: Las personas con enfermedad renal crónica en hemodiálisis
presentan una elevada carga de síntomas que contribuyen para aumentar el sufrimiento y disminuir su calidad de vida. Presentan varios problemas cardiovasculares, musculoesqueléticos y psicosociales que afectan a su ca-pacidad física y funcional, pudiendo aumentar la ansiedad, el estrés y la depresión.
OBJECTIVO(S): Determinar la prevalencia de estrés / ansiedad y
depre-sión en personas con enfermedad renal crónica y verificar la asociación entre el estrés / ansiedad y la depresión con el dolor y la calidad de vida.
MÉTODOS: Estudio transversal, descriptivo y correlacional, Muestra
alea-toria compuesta por 183 pacientes en hemodiálisis; aplicación de la escala de ansiedad depresión y estrés (DASS-21), inventario breve de dolor (BPI) y Medical Outcomes Study Short-Form 12-Item Health Survey (SF-12).
RESULTADOS: La muestra consistió principalmente en hombres (59,6%),
casados (53,8%), de nacionalidad portuguesa (78,7%); con edad media de59,17 años (DP ±14,64), haciendo tratamiento hemodialítico hace 70,9 meses (DP ±54,2). El 76% estaba reformado y el 24% tenía un empleo regu-lar. La prevalencia del estrés y la ansiedad fue del 24% y de la depresión fue del 37,2%.
CONCLUSIONES: El estrés / ansiedad y depresión son prevalentes en
per-sonas con enfermedad renal crónica. El estrés / ansiedad y depresión están asociados a altos niveles de dolor, que afectan las actividades de la vida dia-ria, y a bajos niveles de calidad de vida en los componentes físico y mental.
DESCRIPTORES: Calidad de vida; Depresión; Ansiedad;
Insu-ficiencia renal crónica Submetido em 30-12-2019
Aceite em 02-03-2020
INTRODUCTION
Chronic kidney disease (CKD) was defined as t de-creased kidney function shown by glomerular filtra-tion rate (GFR) of less than 60 ml/min per 1.73 m2, or markers of kidney damage, or both, with a duration of at least 3 months, regardless of the underlying pathol-ogy (Webster, Nagler, Morton & Masson, 2017).
The prevalence of CKD has increased in the last 25 years and it is associated with aging and epidemiologi-cal changes, namely those related with noncommuni-cable diseases such as diabetes and hypertension (Xie et al., 2018). The prevalence of all stages of CKD varies between 7 to 12% worldwide. In Europe, the prevalence ranges from 2.3% in Germany, 2.4% in Finland, 4.0% in Spain to 5.2% in England (Romagnani et al. 2017). However, it is estimated that the prevalence of CKD varies both within the same country and between coun-tries (Glassock, Warnock, & Delanaye, 2017).
Globally, between the years of 1990 and 2016, the cidence of CKD increased by 89%, the prevalence in-creased by 87%, the mortality inin-creased by 98%, and the disability-adjusted life years (DALYs) increased by 62% (Xie et al., 2018).
The person with chronic kidney disease undergoing hemodialysis has a high symptom burden that contrib-utes to increased suffering and diminishes their qual-ity of life (Gutiérrez Sánchez, Leiva-Santos, Sánchez-Hernández, & Gómez García, 2015). These patients have cardiovascular, musculoskeletal and psychosocial disorders that affect their physical and functional ca-pacity (Barbero Narbona et al., 2016). A review of 55 articles published between 1992 and 2009 analyzed the prevalence of pain in hemodialysis patients (with 36 studies examining over 5200 patients) and showed that over 58% of CKD patients experience pain and 49% of patients rate their pain as moderate or severe (Davison, Koncicki, & Brennan, 2014). They also have symptoms and emotional disorders such as anxiety and depression (Gómez Vilaseca, Pac Gracia, Manresa Traguany, Lo-zano Ramírez, & Chevarria Montesinos, 2015) includ-ing stress. Depressive and anxiety symptoms are com-mon acom-mongst individuals with chronic kidney disease and are known to affect quality of life adversely (Pascoe, Thompson, Castle, McEvedy, & Ski, 2017). CKD pa-tients with symptoms of depression, anxiety and stress had poorer quality of life than those without, highlight-ing the negative impact of psychological symptoms in these patients (Bujang et al., 2015).
The aim of this study was to determine the prevalence of stress/anxiety and depression in people with chronic kidney disease and to verify the association between stress/anxiety and depression with pain and quality of life.
METHODS
This is a cross-sectional, descriptive and correlational study. A representative sample of 183 people with CKD who underwent hemodialysis in two clinics and one hospital unit in the region of Lisbon, Portugal, was ob-tained.
The inclusion criteria defined for the population were: people undergoing HD routinely for at least six months and aged 18 years or over. Exclusion criteria were: peo-ple with cognitive impairment and active psychiatric illness. Information regarding these conditions was ob-tained through medical records.
Data was collected from March to June 2015. Inter-views were performed by five trained nurses during the HD session. One of the researchers met with these nurses to explain the objectives and the process of data collection, followed by a written roadmap to assist in completing the data collection instruments.
The data collection instrument consisted of sociode-mographic and health variables, as well as, the depres-sion anxiety and stress scale (DASS-21) (Lovibond, & Lovibond, 1995; Pais-Ribeiro, Honrado, & Leal, 2004; Sousa et al., 2017a) and brief pain Inventory (BPI), and Medical Outcomes Study Short-Form 12-Item Health Survey (SF-12) (Sousa, Marques-Vieira, Severino, Po-zo-Rosado, & José, 2017c). The DASS-21 consists of 21 items distributed in equal numbers by three scales, de-pression, anxiety and stress. The subscale depression is related to the following concepts: depression and dys-phoria (one item); discouragement, (one item); devalu-ation of life (one item); self-deprecidevalu-ation (one item); lack of interest or involvement (one item); anedonia (one item); inertia (one item); the subscale is constitut-ed by the following concepts: anxiety and autonomous system excitation (three items); musculoskeletal effects (one item); situational anxiety (one item); subjective anxiety experiences (two items); the subscale stress re-fers to the concepts: difficulty in relaxing two items); nervous excitement (one item); easily agitated/upset (one item); irritable/exaggerated reaction (two items); and impatience (one item). Each item is character-ized by a statement which refers to negative emotional symptoms.
It intends to evaluate the extent to which they have experienced each symptom during the last week on a four-points Likert scale of severity or frequency: “It did not apply to me at all” to “It applied to me most of the time”. The highest scores on each scale refer to more negative affective states (Lovibond & Lovibond,1995; Pais-Ribeiro, Honrado, & Leal, 2004). The DASS 21 in patients with CKD has a two-dimensional model “De-pression” and “Stress / Anxiety” with valid and repro-ducible measurements (Sousa et al., 2017a).
SF-12 (Ferreira-Valente, Pais Ribeiro, & Jensen, 2012) is a health questionnaire developed in the United States of America, validated for several countries from different continents. It measures the perception of health-related QoL through the use of 12 items with a resumed physi-cal and mental component in which the constructs are evaluated on a Likert type scale from three to five points (Sousa, Antunes, Marques-Vieira, Valentim, & José, 2017b). The version translated and adapted to Portuguese showed reliability and satisfactory validity (Ferreira-Valente et al., 2012).
The abbreviated BPI version consists of a diagram to register the location of the painI on a human figure, and of scales to assess the intensity and impact of pain. Pain intensity is recorded through numerical scales ranging from 0 (no pain) to 10 (the worst possible pain) and by a set of statements about life activities, general activ-ity, mood, ability to walk, work, social relations, sleep capacity and fun, measured on a scale with ten values (from no interference (zero) to complete interference (ten)) (Ferreira-Valente et al., 2012; Sousa et al., 2017c). The Portuguese version of BPI in people with CKD pre-sented two factors, namely pain interference and pain severity, with internal consistency with Cronbach’s al-pha value of 0.82 6 and 0.91respectively (Sousa et al., 2017c).
Data were analyzed with descriptive and inferential sta-tistics using the Statistical Package for Social Sciences (SPSS) 20.0 statistical software. Data obtained by SF-12 was analyzed using the Quality Metric Health Out-comes™ Scoring Software 4.5. The cut-off scores have been developed for defining mild/moderate/severe/ extremely severe scores for each DASS scale (Lovibond & Lovibond, 1995). For the study of the association the Pearson correlation coefficient was used. The level of significance adopted was p <0.05.
Retrospective license was obtained for the use of SF-12 (license No QM030904).
This study was approved by the ethics committee of the two health organizations, approval No 1/2015 of the ethics committees of Diaverum and approval No 175/2015 of the ethics committees of the Centro Hospi-talar Lisboa Central. Both the purpose of the study, and the guaranteed confidentiality of data with the right to withdraw without risk to oneself were explained to the people with CKD. Informed consent was therefore ob-tained from those who met the inclusion criteria and agreed to participate.
RESULTS
The sociodemographic characteristics of participants were: male (59.6%); mean age of 59.17 years old (SD = 14.64). 78.7% had Portuguese nationality and the re-maining were from an African country as follows: Cape Verde 13.7%; São Tomé 3.3%; Angola 2.2% and Guinea 1.6%, and other 0.5%. Concerning the educational level, 3.3% were illiterate, 41.1% had the 4th grade, 18.9% the 6th grade, 15% the 9th grade, 12.2% the 12th grade and 9.4% have completed higher education. Regarding their marital status, most were married (53.8%), 28% were single, 11.5% widowers and 6.6% were divorced. About 76% were retired, only 24% had a regular professional activity. With regards to health data, the subjects were undergoing HD for about 70.9 months (±54.2), 61.9% had hypertension and 25.8% had diabetes.
The prevalence of stress and anxiety is 24% and depres-sion is 37.2%. Depresdepres-sion was classified as mild (5-6) in 10.9% of the sample, moderate (7-10) in 15.3%, severe (11-13) in 5.5% and extremely severe (>14) in 5.5%. Stress/Anxiety was mild (11-15) in 14.2%, moderate (16-20) in 3.8%, severe (21-26) in 4.9% and extremely severe (>27) in 1.1%.
Stress and anxiety had a significant positive correlation with depression (r = 0.729, p <0.001), with pain sever-ity (r = 0.243, p <0.05), pain interference (r = 0.508, p <0.001) and negative with the physical (r = -0.167, p <0.05) and mental (r = -0.477; p <0.001) components of quality of life. Depression was positively and signifi-cantly associated with pain severity (r = 0.248, p <0.01) and pain interference (r = 0.562, p <0.001), but nega-tively with the physical (r = -0.199; p <0.05) and mental (r = -0.516; p <0.01) components of quality of life. The physical component of quality of life is positively asso-ciated with the mental component of quality of life (r = 0.200; p <0.001) and negatively with pain severity (r = -0.341; p <0.001) and pain interference (r= 0.413; p <0.001).
The mental component is negatively correlated with pain interference (r = -0.445; p <0.001), and finally the severity of pain is positively associated with pain interference (r = 0.533, p <0.001).
Stress and
Anxiety (DASS) Depression (DASS) (Physical Component)Quality of Life Mental Component Quality of Life Pain Severity
Stress and Anxiety (DASS)
Depression (DASS) 0.729***
Physical Component Quality of
Life -0.167* -0.248**
Mental Component Quality of Life -0.477*** -0.562*** 0.200**
Pain Severity 0.243* 0.199* -0.341*** -0.177
Pain Interference 0.508*** 0.516** -0.413*** -0.445*** 0.533***
Tabela 1 - Pearson correlation coefficient between the dimensions stress and anxiety, depression, physical component quality of life, mental component quality of life, pain severity and pain interference
Legend: * <0,05; ** p< 0,01; ***p< 0,001.
DISCUSSION
The present study shows a prevalence of depression, anxiety and stress amongst hemodialysis patients. These results are in line with other studies reported in a sys-tematic review and meta-analysis in which depressive symptoms are common in adults with CKD (Palmer et al., 2013). Other authors have reported the prevalence of psychological symptoms (depression and anxiety) and their relationship with a poor quality of life among these patients (Bujang et al., 2015; Gerogianni, Lianos, Kouzoupis, Polikandrioti, & Grapsa, 2018).
In the study where Gerogianni is the first author (2018) the results indicated a significant correlation between anxiety and depression levels in hemodialysis subjects. Participants with high levels of anxiety had higher lev-els of depression. This situation is also confirmed in this study, as higher values of depression are associated with higher values of stress and anxiety.
Still, Yoong in co-authoring (2017) found in two studies performed in people with end-stage renal disease that a total of 233 participants (45.4%) reported elevated anxiety symptoms and 256 (49.9%) had high depres-sive symptoms. In a study of people with CKD, the prevalence of anxiety was 36.5% and depression of 27% (Montilla, Duschek & del Paso, 2016)
The three psychological symptoms (stress, anxiety and depression) are associated with higher pain values and lower values of quality of life in both physical and men-tal components. We can observe other studies in which depressive and anxious symptoms are common among individuals with CKD and are known to negatively affect the quality of life (Bujang et al., 2015; Pascoe, Thompson, Castle, McEvedy, & Ski, 2017).
On the other hand, anxiety and depression are the best predictors of the physical and mental component of quality of life (Montilla et al., 2016).
A Portuguese study with 172 people with CKD on he-modialysis verified that chronic pain occurs in 54.1% of patients and intradialytic pain in 75%, and the causes of pain were musculoskeletal (69.3%) (Sousa et al., 2018). In a study involving people with chronic disease (includ-ing CKD) it was found that the higher the level of co-morbidity (diabetes, neurological sequelae, among oth-ers), the greater the prevalence of depressive symptoms and the higher the level of pain experienced (Sharpe et al., 2017). Similar results were reported in a study in the UK and Ireland involving 893 people on dialysis, who found low levels of quality of life, and a prevalence of pain in 64% of these people. Decreased quality of life was explained by the loss of mobility, pain, depression, diarrhea, drowsiness and loss of appetite (Lowney et al., 2015).
CONCLUSIONS
CKD has become a complex public health problem. During the course of the disease, the impact of the di-agnosis, the coexistence with the disease and the begin-ning of the treatment are situations of stress and anxiety that affect the quality of life. Therefore, knowledge about CKD is essential to solve people’s health problems. This study contributed to identify the prevalence of stress, anxiety and depression in people with CKD and the as-sociation with pain and quality of life.
All psychological variables (stress, anxiety and depres-sion) had a significant and negative impact on the di-mensions of quality of life (physical and mental).
People with symptoms of depression, anxiety and stress had worse quality of life than those without symptoms, which highlights the negative impact on pain severity and interference and shows the need for intervention. Stress, anxiety and depression are more prevalent in people with CKD. High levels of stress, anxiety and de-pression are associated with high levels of pain causing an impact on activities of daily living, and consequent-ly lowering levels of quality of life in the physical and mental components. Nurses should develop strategies to improve the mental health of people with CKD in order to improve their quality of life.
IMPLICATIONS FOR CLINICAL PRACTICE
People on dialysis have experienced psychological symptoms such as depression, anxiety and stress, affect-ing their quality of life, requiraffect-ing intervention. Beaffect-ing the nurse a key player, integrating the multi-profession-al team, responsible for the care of people with CKD, it is important to bear in mind that one of the main ob-jectives of the nursing intervention is to provide maxi-mum well-being and quality of life. The prevalence of stress, anxiety and depression and the association of these variables with a poorer quality of life underlies the importance of a psychotherapeutic nursing inter-vention in the scope of mental health during the dialy-sis treatment. This intervention must always be based in the therapeutic relationship and interpersonal commu-nication between the nurse and the person (Sampaio, Sequeira, & Lluch Canut, 2018).
The psychotherapeutic interventions of the nurse spe-cialist in mental and psychiatric health, may reduce depressive symptoms, stress and anxiety (Sampaio, Araújo, Sequeira, Lluch Canut, & Martins, 2018) and consequently improve the quality of life in people with CKD and their family caregivers. Also, humor inter-vention in nursing performed in people with CKD improved quality of life and subjective well-being, and decreased depressive symptoms (Sousa, 2018). Never-theless, studies indicate the need of further research in this field (Pascoe et al., 2017).
REFERENCES
Barbero Narbona, E., Tejeda Araez, E., Herrera Mo-rales, C., Montserrat García, S., Gascó Coscojuela, N., & Junyent Iglesias, E. (2016). Estudio comparativo del estado físico, mental y percepción de calidad de vida relacionada con la salud de los pacientes en diálisis. Enfermería Nefrológica, 19(1), 29-35. Disponível em: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid =S2254-28842016000100004
Bujang, M. A., Musa, R., Liu, W. J., Chew, T. F., Lim, C. T., & Morad, Z. (2015). Depression, anxiety and stress among patients with dialysis and the association with quality of life. Asian journal of psychiatry, 18, 49-52. doi: 10.1016/j.ajp.2015.10.004
Davison, S. N., Koncicki, H., & Brennan, F. (2014). Pain in chronic kidney disease: a scoping review. Seminars in dialysis, 27(2), 188-204. doi: 10.1111/sdi.12196 Ferreira-Valente, M. A., Pais Ribeiro, J. L., & Jensen, M. P. (2012). Contribución adicional para la validación de la versión portuguesa de la Escala de Interferencia del Inventario Breve de Dolor. Clínica y Salud, 23(1), 89-96. doi: 10.5093/cl2012a6
Gerogianni, G., Lianos, E., Kouzoupis, A., Polikandri-oti, M., & Grapsa, E. (2018). The role of socio-demo-graphic factors in depression and anxiety of patients on hemodialysis: an observational cross-sectional study. International urology and nephrology, 50(1), 143-154. doi: 10.1007/s11255-017-1738-0
Glassock, R. J., Warnock, D. G., & Delanaye, P. (2017). The global burden of chronic kidney disease: estimates, variability and pitfalls. Nature Reviews Nephrology, 13(2), 104-114. doi: 10.1038/nrneph.2016.163
Gómez Vilaseca, L., Pac Gracia, N., Manresa Traguany, M., Lozano Ramírez, S., & Chevarria Montesinos, J. L. (2015). Prevalencia de ansiedad y depresión en paci-entes de hemodiálisis. Enfermería Nefrológica, 18(2), 112-117. doi: 10.4321/S2254-28842015000200006
Gutiérrez Sánchez, D., Leiva-Santos, J. P., Sánchez-Hernández, R., & Gómez García, R. (2015). Prevalencia y evaluación de síntomas en enfermedad renal crónica avanzada. Enfermería Nefrológica, 18(3), 228-236. doi: 10.4321/S2254-28842015000300010
Lovibond, S.H. & Lovibond, P.F. (1995). Manual for the Depression Anxiety Stress Scales. (2nd. Ed.) Syd-ney: Psychology Foundation. Disponível em: www.psy. unsw.edu.au/dass/
Lowney, A. C., Myles, H. T., Bristowe, K., Lowney, E. L., Shepherd, K., Murphy, M., et al. (2015). Under-standing what influences the health-related quality of life of hemodialysis patients: a collaborative study in England and Ireland. Journal of pain and symptom management, 50(6), 778-785. doi: 10.1016/j.jpainsym-man.2015.07.010
Montilla, C. M. P., Duschek, S., & del Paso, G. A. R. (2016). Calidad de vida relacionada con la salud en la enfermedad renal crónica: relevancia predictiva del es-tado de ánimo y la sintomatología somática. nefrologia, 36(3), 275-282. doi: 10.1016/j.nefro.2015.12.002
Pais-Ribeiro, J. L., Honrado, A., & Leal, I. (2004). Con-tribuição para o estudo da adaptação portuguesa das escalas de ansiedade, depressão e stress (EADS) de 21 itens de Lovibond e Lovibond. Psicologia, saúde & doenças, 5(2), 229-239. Disponível em: http://www.sci-elo.mec.pt/pdf/psd/v5n2/v5n2a07.pdf
Palmer, S., Vecchio, M., Craig, J. C., Tonelli, M., John-son, D. W., Nicolucci, Aet al. (2013). Prevalence of de-pression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney in-ternational, 84(1), 179-191. doi: 10.1038/ki.2013.77 Pascoe, M. C., Thompson, D. R., Castle, D. J., McEvedy, S. M., & Ski, C. F. (2017). Psychosocial Interventions for Depressive and Anxiety Symptoms in Individuals with Chronic Kidney Disease: Systematic Review and Meta-Analysis. Frontiers in psychology, 8, 992. doi: 10.3389/ fpsyg.2017.00992
Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., et al. (2017). Chronic kidney disease. Nature Reviews Disease Primers, 3,17088, 1-24. doi: 10.1038/nrdp.2017.88
Sampaio, F., Araújo, O., Sequeira, C., Lluch Canut, T., & Martins, T. (2018). A randomized controlled trial of a nursing psychotherapeutic intervention for anxiety in adult psychiatric outpatients. Journal of Advanced Nursin, 74 (5), 1114-1126. doi: 10.1111/jan.13520 Sampaio, F., Sequeira, C., & Lluch Canut, T. (2018). Modelo de intervenção psicoterapêutica em enferma-gem: Princípios orientadores para a implementação na prática clínica. Revista Portuguesa de Enfermagem de Saúde Mental, (19), 77-84. doi: 10.19131/rpesm.0205 Sharpe, L., McDonald, S., Correia, H., Raue, P. J., Meade, T., Nicholas et al (2017). Pain severity predicts depres-sive symptoms over and above individual illnesses and multimorbidity in older adults. BMC psychiatry, 17 (1), 166. doi: 10.1186/s12888-017-1334-y
Sousa, L. (2018). Ganhos em saúde com a intervenção “humor” em pessoas com doença renal crónica [Gains in health with “humor” intervention in people with chronic kidney disease]. (Tese de Doutoramento). Uni-versidade Católica Portuguesa, Portugal. Disponível em: http://hdl.handle.net/10400.14/26059
Sousa, L. M. M. D., Marques-Vieira, C. M. A., Severino, S. S. P., Pozo-Rosado, J. L., Gomes, J. C. R., & José, H. M. G. (2017a). A Depression Anxiety Stress Scale em pessoas com doença renal crónica. Revista Portugue-sa de Enfermagem de Saúde Mental, (17), 50-57. doi: 10.19131/rpesm.0182
Sousa, L. M., Antunes, A. V., Marques-Vieira, C., Val-entim, O. S., & José, H. M. (2017b). Qualidade de vida e pessoa com doença renal crónica: um estudo trans-versal. In R Missias-Moreira, Z.N. Sales, L.C.G. Nas-cimento, O.S. Valentim (Eds). Qualidade de vida e condições de saúde de diversas populações 2. (139-54). Curitiba: Editora CRV. Disponível em: http://dx.doi. org/10.24824/978854441793.5
Sousa, L. M.M., Marques-Vieira, C. M., Severino, S., Pozo-Rosado, J. L., & José, H. M. (2017c). Validación del Brief Pain Inventory en personas con enfermedad renal crónica. Aquichan, 17 (1), 42-52. doi: 10.5294/ aqui.2017.17.1.5
Sousa, L., Marques-Vieira, C., Severino, S., Firmino, C., Antunes, A.V. & José, H. (2018). Assessment of pain and effectiveness of analgesia in patient undergoing haemodialysis. (O97). BMC Health Services Research, 18(Suppl 2), 53-54. Disponível em: http://hdl.handle. net/20.500.12253/1364
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017). Chronic kidney disease. The Lancet, 389(10075), 1238-1252. doi:10.1016/S0140-6736(16)32064-5
Xie, Y., Bowe, B., Mokdad, A. H., Xian, H., Yan, Y., Li, T., et al. (2018). Analysis of the Global Burden of Dis-ease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney international, 94(3), 567-581. doi: 10.1016/j.kint.2018.04.011
Yoong, R. K., Mooppil, N., Khoo, E. Y., Newman, S. P., Lee, V. Y., Kang, A. W., & Griva, K. (2017). Preva-lence and determinants of anxiety and depression in end stage renal disease (ESRD). A comparison between ESRD patients with and without coexisting diabetes mellitus. Journal of psychosomatic research, 94, 68-72. doi: 10.1016/j.jpsychores.2017.01.009
